Community practices looking to sustain growth are going to need to use technology, explained Terrill Jordan, chief executive officer of Regional Cancer Care Associates.
Community practices looking to sustain growth are going to need to use technology, explained Terrill Jordan, chief executive officer of Regional Cancer Care Associates.
Transcript
What are best strategies for community practices trying to achieve sustainable growth?
Practices that are trying to sustain growth, I think those challenges are still the same. I think what you’re going to find is they need to use technology. Here being at OncoCloud is a perfect example. You’re going to need to use the technologies that are available so that you can grow more and be more efficient. If you want to grow and you want to stay competitive, it’s about how you use technology to further your clinicians’ ability to see more patients.
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More